Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
Researchers have given nanoparticles the ability to tell immune cells not to eat them, a development that could have broad implications for medicine.
The drug giant is hoping to boost its innovation pipeline with new funding for early-stage biotechnology research.
Norman Priebatsch, who disappeared on Sunday while hiking, had recently founded a company working on a novel solution for tinnitus.
Researchers hope to combine the sensor with a device to deliver targeted chemotherapy.
A synthetic material may help to repair tissue after a heart attack, and aid transplants.
The new material, which can be injected, molded, and set in place by exposure to light, could benefit people disfigured by disease or injury.
Unlike other systems, Ion Torrent’s technology promises to improve in step with advances in electronics—and it’s already proving useful for public health.
Need to track your blood oxygen levels? There may soon be an app for that.
A commercial test could let doctors easily screen for major depressive disorder.